rs373057251
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The ENST00000334785.12(NEXN):āc.1471G>Cā(p.Glu491Gln) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000115 in 1,596,438 control chromosomes in the GnomAD database, with no homozygous occurrence. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ā ). Synonymous variant affecting the same amino acid position (i.e. E491E) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000334785.12 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEXN | NM_144573.4 | c.1471G>C | p.Glu491Gln | missense_variant, splice_region_variant | 11/13 | ENST00000334785.12 | NP_653174.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEXN | ENST00000334785.12 | c.1471G>C | p.Glu491Gln | missense_variant, splice_region_variant | 11/13 | 1 | NM_144573.4 | ENSP00000333938 | P3 | |
NEXN | ENST00000342754.5 | c.1171G>C | p.Glu391Gln | missense_variant, splice_region_variant | 7/10 | 1 | ENSP00000343928 | |||
NEXN | ENST00000330010.12 | c.1279G>C | p.Glu427Gln | missense_variant, splice_region_variant | 10/12 | 2 | ENSP00000327363 | A1 | ||
NEXN | ENST00000480732.2 | n.1045G>C | splice_region_variant, non_coding_transcript_exon_variant | 3/5 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152172Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000362 AC: 9AN: 248760Hom.: 0 AF XY: 0.0000444 AC XY: 6AN XY: 135166
GnomAD4 exome AF: 0.000123 AC: 177AN: 1444266Hom.: 0 Cov.: 27 AF XY: 0.000113 AC XY: 81AN XY: 719676
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152172Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74334
ClinVar
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 11, 2013 | p.Glu491Gln (GAG>CAG): c.1471 G>C in exon 11 of the NEXN gene (NM_144573.3). The Glu491Gln variant in the NEXN gene has not been reported as a disease-causing mutation or as a benign polymorphism to our knowledge. Glu491Gln results in a semi-conservative amino acid substitution of a negatively charged Glutamic acid residue with a neutral, polar Glutamine residue at a position that is conserved across species. In silico analysis predicts Glu491Gln is probably damaging to the protein structure/function. The Glu491Gln variant was not observed with any significant frequency in approximately 5,800 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project. Nevertheless, no mutations affecting nearby residues have been reported in association with cardiomyopathy, indicating this region of the protein may be tolerant of change. With the clinical and molecular information available at this time, we cannot definitively determine if Glu491Gln is a disease-causing mutation or a rare benign variant. The variant is found in DCM,DCM-CRDM panel(s). - |
Uncertain significance, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Dilated cardiomyopathy 1CC;C3151267:Hypertrophic cardiomyopathy 20 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 13, 2022 | This variant is present in population databases (rs373057251, gnomAD 0.01%). This sequence change replaces glutamic acid, which is acidic and polar, with glutamine, which is neutral and polar, at codon 491 of the NEXN protein (p.Glu491Gln). This variant has not been reported in the literature in individuals affected with NEXN-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 201926). - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Aug 05, 2021 | - - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 14, 2019 | The p.E491Q variant (also known as c.1471G>C), located in coding exon 10 of the NEXN gene, results from a G to C substitution at nucleotide position 1471. The glutamic acid at codon 491 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at